Archives

Interest in self-care has exploded in recent years, highlighting its crucial role in shaping future healthcare systems. Imperial SCARU’s Dr Austen El-Osta discusses emerging trends, research priorities and self-care policy landscapes, advocating for a global movement towrds accessible and empowered health management.

Dr Priya Hays, Ph.D., CEO/Science Writer at Hays Documentation Specialists, LLC, responds to “Tyranny of the Gene.” Is personalized medicine a threat to public health? Not really, but yes, it’s an argument for price controls and perhaps more regulations; we hear.

Given the increasing threat of antimicrobial resistance, Gunther Vanwezer, CEO of Vésale Bioscience, explains how bacteriophages offer a promising natural solution and outlines the company’s efforts to become a pioneer in the development of innovative, personalised and sustainable phage-based therapy solutions.

3Deus Dynamics has raised €2.5 million for the industrialization of its 3D process, to expand internationally and revolutionize personalized medicine with Dynamic Molding.

Professor Hamdy Awad, MD, FASA, from the Ohio State University Wexner Medical Center, examines the dangers of aortic aneurysm surgery and the importance of continued research towards eliminating paralysis.

Erika Dyck delves into the history of psychedelics, exploring how these substances have piqued the interest and influenced the attitudes of individuals across academia, culture, and medicine.

Tailoring care to meet patients’ needs can dramatically improve clinical outcomes; we hear how the IC2PerMed project is bolstering efforts in personalised medicine.

Professor Michael Levin from Imperial College London argues that in the DIAMONDS project, there has been a breakthrough response in personalized medicine via RNA molecular signature diagnosis.